CD8A and colorectal cancer: CD8+, Th1, Th2, follicular helper T cells, and T cell markers are significantly higher in patients with MSI-H/dMMR colorectal cancer than in microsatellite stable (MSS)/MMR protein-proficient (pMMR) colorectal cancer [48].